2Qureshi H,Zuberi SJ,Lodi TZ,et al.Clinical features,course,viral markers and follow-up in young versus adult nonalcoho1ic cirrhotics:a retrospective study[J].Digestion,1989,42(2):110.
4Schliching P. Main in causes darth in cirrhosis[J]. Scand J Gastroenterol, 1983, 18: 881.
5Rigau J, Bosch J,Bordas J M, et al. Endoscopic measurement of variceal pressure in cirrhosis: correlation with portal pressure and variced hemorrhage[J]. Gastroenterology, 1989, 96: 873.
6Caregaro L, Alberino F, Amodio P, et al. Nutritional and Prognostic Significance of insulin-like growth factor 1 in patients with Liver Cirrhosis[J]. Nutrition, 1997, 13: 185.
7Assaad S N, Cunningham G R, Samaan N A, et al. Abnormal growth hormone dynamics in chronic liver disease do not depend on severe parenchymal disease[J]. Metabolism, 1990, 39: 349.
9Benoit J N, Womack W A, Hernandez L, et al."Foward" and "Backward" flow mechanisms of portal hypertension relative contribntion in the rat model of portal vein stenosis[J]. Gastroenterology, 1985, 89: 1092.
10Moller S, Juul A, Becker U, et al. Concentrations,release,and diesposal of insulin-like growth factor-binding proteins, IGF-I, and growth hormone in different vascular beds in patients with cirrhosis[J]. J Clin Endocrin Metab, 1995, 80: 1148.
9POLAT KY, AKCAY MN, AYDINLI B, et al. Spontaneous mpture of hepatoeellular carcinoma:a case report and review of literature [J]. Int J Clin Pract SupN,2008,147(1): 103- 105.
10TANAKA S, ARII S. Molecularly targeted therapy for hep atocellular carcinoma[J]. Cancer Science, 2009,100 ( 1 ) : 1-8.
